Organon & Co. (OGN)
13.76
0.00 (0.00%)
USD |
NYSE |
Oct 16, 16:00
13.76
0.00 (0.00%)
After-Hours: 20:00
Organon Cash from Operations (Quarterly) : 107.00M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 107.00M |
| March 31, 2026 | 225.00M |
| December 31, 2025 | 141.00M |
| September 30, 2025 | 264.00M |
| June 30, 2025 | 220.00M |
| March 31, 2025 | 75.00M |
| December 31, 2024 | 390.00M |
| September 30, 2024 | 141.00M |
| June 30, 2024 | 332.00M |
| March 31, 2024 | 76.00M |
| December 31, 2023 | 397.00M |
| September 30, 2023 | 261.00M |
| June 30, 2023 | 27.00M |
| Date | Value |
|---|---|
| March 31, 2023 | 114.00M |
| December 31, 2022 | 267.00M |
| September 30, 2022 | 317.00M |
| June 30, 2022 | 151.00M |
| March 31, 2022 | 123.00M |
| December 31, 2021 | 181.00M |
| September 30, 2021 | 70.00M |
| June 30, 2021 | 1.472B |
| March 31, 2021 | 735.00M |
| December 31, 2020 | 387.00M |
| September 30, 2020 | 331.00M |
| June 30, 2020 | 803.00M |
| March 31, 2020 | 666.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Merck & Co., Inc. | 5.37B |
| Viatris, Inc. | 381.80M |
| Pfizer Inc. | 835.00M |
| Pacira Biosciences, Inc. | 57.46M |
| Bristol Myers Squibb Co. | 3.393B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -76.00M |
| Cash from Financing (Quarterly) | -12.00M |
| Free Cash Flow | 558.00M |
| Free Cash Flow Per Share (Quarterly) | 0.1146 |
| Free Cash Flow to Equity (Quarterly) | 47.00M |
| Free Cash Flow to Firm (Quarterly) | 96.51M |
| Free Cash Flow Yield | 15.39% |